189 related articles for article (PubMed ID: 15364332)
1. Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis.
Kaufman ES; Zimmermann PA; Wang T; Dennish GW; Barrell PD; Chandler ML; Greene HL;
J Am Coll Cardiol; 2004 Sep; 44(6):1276-82. PubMed ID: 15364332
[TBL] [Abstract][Full Text] [Related]
2. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
[TBL] [Abstract][Full Text] [Related]
3. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.
Chung MK; Shemanski L; Sherman DG; Greene HL; Hogan DB; Kellen JC; Kim SG; Martin LW; Rosenberg Y; Wyse DG;
J Am Coll Cardiol; 2005 Nov; 46(10):1891-9. PubMed ID: 16286177
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.
Sherman DG; Kim SG; Boop BS; Corley SD; Dimarco JP; Hart RG; Haywood LJ; Hoyte K; Kaufman ES; Kim MH; Nasco E; Waldo AL;
Arch Intern Med; 2005 May; 165(10):1185-91. PubMed ID: 15911734
[TBL] [Abstract][Full Text] [Related]
5. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
[TBL] [Abstract][Full Text] [Related]
6. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Flaker GC; Belew K; Beckman K; Vidaillet H; Kron J; Safford R; Mickel M; Barrell P;
Am Heart J; 2005 Apr; 149(4):657-63. PubMed ID: 15990749
[TBL] [Abstract][Full Text] [Related]
7. Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study).
Freudenberger RS; Wilson AC; Kostis JB;
Am J Cardiol; 2007 Jul; 100(2):247-52. PubMed ID: 17631079
[TBL] [Abstract][Full Text] [Related]
8. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Steinberg JS; Sadaniantz A; Kron J; Krahn A; Denny DM; Daubert J; Campbell WB; Havranek E; Murray K; Olshansky B; O'Neill G; Sami M; Schmidt S; Storm R; Zabalgoitia M; Miller J; Chandler M; Nasco EM; Greene HL
Circulation; 2004 Apr; 109(16):1973-80. PubMed ID: 15051639
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation.
Roy D; Rowe BH; Stiell IG; Coutu B; Ip JH; Phaneuf D; Lee J; Vidaillet H; Dickinson G; Grant S; Ezrin AM; Beatch GN;
J Am Coll Cardiol; 2004 Dec; 44(12):2355-61. PubMed ID: 15607398
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
[TBL] [Abstract][Full Text] [Related]
11. Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study.
Curtis AB; Seals AA; Safford RE; Slater W; Tullo NG; Vidaillet H; Wilber DJ; Slee A
Am Heart J; 2005 Feb; 149(2):304-8. PubMed ID: 15846269
[TBL] [Abstract][Full Text] [Related]
12. [Drug therapy of atrial fibrillation].
Fazekas T; Csanádi Z; Varró A
Orv Hetil; 2003 Jun; 144(24):1199-206. PubMed ID: 12866149
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
[TBL] [Abstract][Full Text] [Related]
14. Impact of lipid-lowering therapy on outcomes in atrial fibrillation.
Badheka AO; Rathod A; Kizilbash MA; Garg N; Mohamad T; Afonso L; Jacob S
Am J Cardiol; 2010 Jun; 105(12):1768-72. PubMed ID: 20538128
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the impact of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management trial on prescribing patterns: a time-series analysis.
Choudhry NK; Zagorski B; Avorn J; Levin R; Sykora K; Laupacis A; Mamdani M
Ann Pharmacother; 2008 Nov; 42(11):1563-72. PubMed ID: 18827174
[TBL] [Abstract][Full Text] [Related]
16. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database).
O'Hara GE; Charbonneau L; Chandler M; Vidaillet HJ; Philippon F; Sami M; Rocco TA; Padder FA; Champagne J; Pratt CM; Coutu B; Wyse DG;
Am J Cardiol; 2005 Sep; 96(6):815-21. PubMed ID: 16169368
[TBL] [Abstract][Full Text] [Related]
17. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
[TBL] [Abstract][Full Text] [Related]
18. Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia.
Shiga T; Tanaka K; Kato R; Amino M; Matsudo Y; Honda T; Sagara K; Takahashi A; Katoh T; Urashima M; Ogawa S; Takano T; Kasanuki H;
Resuscitation; 2010 Jan; 81(1):47-52. PubMed ID: 19913983
[TBL] [Abstract][Full Text] [Related]
19. Rate control versus rhythm control.
Vidaillet H; Greenlee RT
Curr Opin Cardiol; 2005 Jan; 20(1):15-20. PubMed ID: 15596954
[TBL] [Abstract][Full Text] [Related]
20. The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events.
Almroth H; Andersson T; Fengsrud E; Friberg L; Linde P; Rosenqvist M; Englund A
J Intern Med; 2011 Sep; 270(3):281-90. PubMed ID: 21635583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
